nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0432	0.0432	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0432	0.0432	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—SLC6A4—conduct disorder	0.0367	0.0367	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—SLC6A4—conduct disorder	0.0367	0.0367	CbGpPWpGaD
Ramelteon—CYP1A2—Methylation—COMT—conduct disorder	0.0348	0.0348	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—DRD4—conduct disorder	0.0345	0.0345	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—DRD4—conduct disorder	0.0345	0.0345	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—CGA—conduct disorder	0.0329	0.0329	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—CGA—conduct disorder	0.0329	0.0329	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.0304	0.0304	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.0304	0.0304	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0282	0.0282	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0282	0.0282	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0242	0.0242	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0242	0.0242	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0218	0.0218	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—CGA—conduct disorder	0.0186	0.0186	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—CGA—conduct disorder	0.0186	0.0186	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—DRD4—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—DRD4—conduct disorder	0.0184	0.0184	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—CGA—conduct disorder	0.0169	0.0169	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—CGA—conduct disorder	0.0169	0.0169	CbGpPWpGaD
Ramelteon—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0168	0.0168	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0158	0.0158	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0158	0.0158	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0148	0.0148	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—HTR2A—conduct disorder	0.012	0.012	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—HTR2A—conduct disorder	0.012	0.012	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—EP300—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—EP300—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD4—conduct disorder	0.0104	0.0104	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD4—conduct disorder	0.0104	0.0104	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CGA—conduct disorder	0.00997	0.00997	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CGA—conduct disorder	0.00997	0.00997	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD4—conduct disorder	0.00945	0.00945	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD4—conduct disorder	0.00945	0.00945	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00858	0.00858	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—WASF1—conduct disorder	0.00799	0.00799	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—WASF1—conduct disorder	0.00799	0.00799	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00679	0.00679	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00679	0.00679	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00668	0.00668	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR2A—conduct disorder	0.00617	0.00617	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR2A—conduct disorder	0.00617	0.00617	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00611	0.00611	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD4—conduct disorder	0.00559	0.00559	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD4—conduct disorder	0.00559	0.00559	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00516	0.00516	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—COMT—conduct disorder	0.00459	0.00459	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.00456	0.00456	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00453	0.00453	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.0044	0.0044	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.0044	0.0044	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR2A—conduct disorder	0.00364	0.00364	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR2A—conduct disorder	0.00364	0.00364	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00358	0.00358	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00355	0.00355	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00353	0.00353	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00304	0.00304	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—COMT—conduct disorder	0.00276	0.00276	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EP300—conduct disorder	0.00193	0.00193	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EP300—conduct disorder	0.00193	0.00193	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CGA—conduct disorder	0.00174	0.00174	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CGA—conduct disorder	0.00135	0.00135	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CGA—conduct disorder	0.00105	0.00105	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—COMT—conduct disorder	0.000785	0.000785	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MAOA—conduct disorder	0.000779	0.000779	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000756	0.000756	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—COMT—conduct disorder	0.000612	0.000612	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MAOA—conduct disorder	0.000607	0.000607	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000589	0.000589	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—COMT—conduct disorder	0.000472	0.000472	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MAOA—conduct disorder	0.000469	0.000469	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—EP300—conduct disorder	0.000337	0.000337	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—EP300—conduct disorder	0.000262	0.000262	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—EP300—conduct disorder	0.000202	0.000202	CbGpPWpGaD
